<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00675298</url>
  </required_header>
  <id_info>
    <org_study_id>2010P000226</org_study_id>
    <secondary_id>R01DK081647</secondary_id>
    <nct_id>NCT00675298</nct_id>
  </id_info>
  <brief_title>Linkage Analysis in Interstitial Cystitis</brief_title>
  <acronym>IC</acronym>
  <official_title>Genetic Studies of Urologic Chronic Pelvic Pain Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Urologic pelvic pain syndrome (UCPPS), variably termed painful bladder syndrome/interstitial
      cystitis (PBS/IC) in females and chronic prostatitis/chronic pelvic pain syndrome in men
      (CP/CPPS), is a chronic, debilitating clinical syndrome presenting as severe pelvic pain with
      extreme urinary urgency and frequency in the absence of any known cause. The etiologic
      mechanisms underlying UCPPS are unknown, but recurrence, risks to siblings of affected
      individuals, concordance among monozygotic twins, and our own preliminary studies indicate a
      strong genetic contribution to the cause of UCPPS. The overall goal of this proposal is use
      novel approaches to understand the basis of UCPPS, to identify candidate genes containing
      mutations that result in UCPPS and determine how the different encoded proteins of these
      genes interact with one another in a common biological pathway. Ultimately, understanding how
      mutations in at least five different genes yield the symptoms of UCPPS should lead to
      improved diagnosis and possible therapies.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Prostatitis</condition>
  <condition>Cystitis, Interstitial</condition>
  <condition>Urinary Bladder, Overactive</condition>
  <condition>Chronic Pelvic Pain Syndrome</condition>
  <condition>Painful Bladder Syndrome</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Men with chronic prostatitis/chronic pelvic pain syndrome</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Women with painful bladder syndrome/interstitial cystitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Children with overactive bladder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>Bulgarian cohort with chronic prostatitis/chronic pelvic pain syndrome, painful bladder syndrome/interstitial cystitis and children with overactive bladder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <description>Asymptomatic healthy controls</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva and urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Self-referred patients and subjects from a Bulgarian high-prevalence CPPS population
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have symptoms for at least 3 months within the preceding 6 months:

          -  Pain in the pelvic area

          -  Urinary frequency and/or

          -  Urinary urgency and/or

          -  Sexual dysfunction (erectile dysfunction)

          -  Have CP/CPPS, IC, PBS, or BFS

          -  Be willing to provide a saliva and urine sample

          -  Agree to complete several brief questionnaires

          -  Family of someone with CP/CPPS, PBS, IC or BFS

          -  Live in the USA or Canada

        Exclusion Criteria:

          -  Major structural/anatomical urinary tract abnormalities

          -  Underlying inborn or congenital conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jordan D Dimitrakoff, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jordan D Dimitrakoff</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dimitrakov J, Joffe HV, Soldin SJ, Bolus R, Buffington CA, Nickel JC. Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology. 2008 Feb;71(2):261-6. doi: 10.1016/j.urology.2007.09.025.</citation>
    <PMID>18308097</PMID>
  </reference>
  <reference>
    <citation>Dimitrakov J, Kroenke K, Steers WD, Berde C, Zurakowski D, Freeman MR, Jackson JL. Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review. Arch Intern Med. 2007 Oct 8;167(18):1922-9. Review. Erratum in: Arch Intern Med. 2007 Dec 10-22;167(22):2452.</citation>
    <PMID>17923590</PMID>
  </reference>
  <reference>
    <citation>Dimitrakov JD, Kaplan SA, Kroenke K, Jackson JL, Freeman MR. Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach. Urology. 2006 May;67(5):881-8. Review.</citation>
    <PMID>16698346</PMID>
  </reference>
  <reference>
    <citation>Dimitrakov JD. A case of familial clustering of interstitial cystitis and chronic pelvic pain syndrome. Urology. 2001 Aug;58(2):281.</citation>
    <PMID>11489726</PMID>
  </reference>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2008</study_first_submitted>
  <study_first_submitted_qc>May 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2008</study_first_posted>
  <last_update_submitted>February 2, 2017</last_update_submitted>
  <last_update_submitted_qc>February 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2017</last_update_posted>
  <responsible_party>
    <name_title>Jordan Dimitrakoff, MD, PhD</name_title>
    <organization>Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA</organization>
  </responsible_party>
  <keyword>Prostatitis</keyword>
  <keyword>Cystitis, Interstitial</keyword>
  <keyword>Urinary Bladder, Overactive</keyword>
  <keyword>Chronic pelvic pain syndrome</keyword>
  <keyword>Painful bladder syndrome</keyword>
  <keyword>Urgency</keyword>
  <keyword>Frequency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
    <mesh_term>Pelvic Pain</mesh_term>
    <mesh_term>Cystitis</mesh_term>
    <mesh_term>Prostatitis</mesh_term>
    <mesh_term>Cystitis, Interstitial</mesh_term>
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

